Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2022-05-16
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Mapping Epileptic Networks Using Multimodal Imaging
NCT06202976
Spectral Dynamic Imaging of Cognitive Functions in Epileptic Patients Explored Stereoelectroencephalography
NCT02869698
Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
NCT04986683
Localizing the Epileptogenic Zone With High Resolution Electroencephalography
NCT01090934
Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy
NCT00194870
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with epilepsy
Epilepsy surgery will be performed as a part of the clinical management of patients with drug-resistant epilepsy.
Epilepsy surgery
Epilepsy surgery will be performed as a part of the clinical management of patients with drug-resistant epilepsy.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Epilepsy surgery
Epilepsy surgery will be performed as a part of the clinical management of patients with drug-resistant epilepsy.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
6 Months
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wayne State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eishi Asano
Professor of Pediatrics and Neurology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eishi Asano, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Wayne State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital of Michigan
Detroit, Michigan, United States
Wayne State University
Detroit, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
048404MP2E
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.